Loading...
XNAS
UG
Market cap32mUSD
Jul 09, Last price  
7.23USD
1D
0.73%
1Q
10.50%
Jan 2017
-53.34%
Name

United-Guardian Inc

Chart & Performance

D1W1MN
XNAS:UG chart
P/E
15.78
P/S
3.15
EPS
0.46
Div Yield, %
8.36%
Shrs. gr., 5y
Rev. gr., 5y
-0.82%
Revenues
11m
-13.43%
12,195,67211,888,56212,292,14713,276,98413,723,07414,338,51213,825,76415,416,89313,449,67914,006,24410,776,86712,968,20513,769,40113,599,08410,986,08113,929,62912,698,50310,885,15412,181,97110,545,468
Net income
2m
-35.23%
2,737,2323,544,3083,162,9313,878,9633,799,6924,716,5304,830,7805,903,3094,050,4164,606,9292,581,1423,844,2904,352,3314,761,7113,304,9784,658,5422,569,5122,581,3703,250,8752,105,738
CFO
2m
-43.26%
2,076,7974,157,0583,412,3854,337,4484,093,3184,437,1295,380,7475,805,0864,480,7525,199,9722,290,4443,992,2874,950,4124,476,1113,594,2405,313,2772,525,1693,144,4803,466,2511,966,819
Dividend
Jul 25, 20250.25 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
IPO date
Mar 17, 1980
Employees
23
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT